Adenosine A2B receptors modulate cAMP levels and induce CREB but not ERK1/2 and p38 phosphorylation in rat skeletal muscle cells

Biochemical and Biophysical Research Communications

Volumn 307, Issue 1, 2003, Pages 180-187

  Lynge, Jan ^a   Schulte, Gunnar ^b   Nordsborg, Nikolai ^a   Fredholm, Bertil B ^b   Hellsten, Ylva ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cyclic AMP response element binding protein; Extracellular signal regulated protein kinase 1 and 2; Mitogen activated protein kinase; Stress activated protein kinase; Transcription factor

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORSKOLIN; ISOPRENALINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PERTUSSIS TOXIN; PHENYLISOPROPYLADENOSINE; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVATION; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SKELETAL MUSCLE;

EID: 0037711618     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01125-2     Document Type: Article

References (50)

1. Fredholm B.B., IJzerman A.P., Jacobson K.A., Klotz K.N., Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53:2001;527-552.
2. van Calker D., Muller M., Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33:1979;999-1005.
3. Londos C., Cooper D.M., Wolff J. Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. USA. 77:1980;2551-2554.
4. Fredholm B.B., Arslan G., Halldner L., Kull B., Schulte G., Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch. Pharmacol. 362:2000;364-374.
5. Fredholm B.B., Arslan G., Kull B., Kontny E., Svenningsson P. Adenosine (P1) receptor signalling. Drug Dev. Res. 39(3-4):1996;262-268.
6. Berne R.M., Rubio R., Dobson J.G. Jr., Curnish R.R. Adenosine and adenine nucleotides as possible mediators of cardiac and skeletal muscle blood flow regulation. Circ. Res. 28(Suppl. 1):1971;115.
7. Radegran G., Hellsten Y. Adenosine and nitric oxide in exercise-induced human skeletal muscle vasodilatation. Acta Physiol. Scand. 168:2000;575-591.
8. Espinal J., Challiss R.A., Newsholme E.A. Effect of adenosine deaminase and an adenosine analogue on insulin sensitivity in soleus muscle of the rat. FEBS Lett. 158:1983;103-106.
9. Vergauwen L., Hespel P., Richter E.A. Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle. J. Clin. Invest. 93:1994;974-981.
10. 2+ concentrations and twitch tension by adenosine receptor blockade in Rana pipiens. J. Physiol. Lond. 481:1994;129-137.
11. Lynge J., Hellsten Y. Distribution of adenosine A1, A2A and A2B receptors in human skeletal muscle. Acta Physiol. Scand. 169:2000;283-290.
12. Sitaraman S.V., Merlin D., Wang L., Wong M., Gewirtz A.T., Si-Tahar M., Madara J.L. Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J. Clin. Invest. 107:2001;861-869.
13. Mayr B., Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell. Biol. 2:2001;599-609.
14. Withers D.J. Signalling pathways involved in the mitogenic effects of cAMP. Clin. Sci. (Lond.). 92:1997;445-451.
15. Stork P.J., Schmitt J.M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12:2002;258-266.
16. Houslay M.D., Kolch W. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol. Pharmacol. 58:2000;659-668.
17. Schulte G., Fredholm B.B. Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol. Pharmacol. 58:2000;477-482.
18. Sexl V., Mancusi G., Holler C., Gloria M.E., Schutz W., Freissmuth M. Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. J. Biol. Chem. 272:1997;5792-5799.
19. Feoktistov I., Goldstein A.E., Biaggioni I. Role of p38 mitogen-activated protein kinase and extracellular signal- regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. Mol. Pharmacol. 55:1999;726-734.
20. Robinson A.J., Dickenson J.M. Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells. Eur. J. Pharmacol. 413:2001;151-161.
21. Ryder J.W., Fahlman R., Wallberg-Henriksson H., Alessi D.R., Krook A., Zierath J.R. Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle. Involvement of the mitogen- and stress-activated protein kinase 1. J. Biol. Chem. 275:2000;1457-1462.
22. Hayashi T., Hirshman M.F., Dufresne S.D., Goodyear L.J. Skeletal muscle contractile activity in vitro stimulates mitogen-activated protein kinase signaling. Am. J. Physiol. 277:1999;C701-C707.
23. Widegren U., Jiang X.J., Krook A., Chibalin A.V., Bjornholm M., Tally M., Roth R.A., Henriksson J., Wallberg-Henriksson H., Zierath J.R. Divergent effects of exercise on metabolic and mitogenic signaling pathways in human skeletal muscle. FASEB J. 12:1998;1379-1389.
24. Widegren U., Ryder J.W., Zierath J.R. Mitogen-activated protein kinase signal transduction in skeletal muscle: effects of exercise and muscle contraction. Acta Physiol. Scand. 172:2001;227-238.
25. Sweeney G., Somwar R., Ramlal T., Volchuk A., Ueyama A., Klip A. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J. Biol. Chem. 274:1999;10071-10078.
26. Somwar R., Perreault M., Kapur S., Taha C., Sweeney G., Ramlal T., Kim D.Y., Keen J., Cote C.H., Klip A., Marette A. Activation of p38 mitogen-activated protein kinase alpha and beta by insulin and contraction in rat skeletal muscle: potential role in the stimulation of glucose transport. Diabetes. 49:2000;1794-1800.
27. Bennett A.M., Tonks N.K. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science. 278:1997;1288-1291.
28. Adi S., Bin-Abbas B., Wu N.Y., Rosenthal S.M. Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation. Endocrinology. 143:2002;511-516.
29. Hellsten Y., Frandsen U. Adenosine formation in contracting primary rat skeletal muscle cells and endothelial cells in culture. J. Physiol. Lond. 504:1997;695-704.
30. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
31. Pilegaard H., Ordway G.A., Saltin B., Neufer P.D. Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am. J. Physiol. Endocrinol. Metab. 279:2000;E806-E814.
32. Feoktistov I., Biaggioni I. Adenosine A2B receptors. Pharmacol. Rev. 49:1997;381-402.
33. Bruns R.F. Adenosine antagonism by purines, pteridines and benzopteridines in human fibroblasts. Biochem. Pharmacol. 30:1981;325-333.
34. Feoktistov I., Biaggioni I. Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes. Mol. Pharmacol. 43:1993;909-914.
35. Brackett L.E., Daly J.W. Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts. Biochem. Pharmacol. 47:1994;801-814.
36. Dionisotti S., Ongini E., Zocchi C., Kull B., Arslan G., Fredholm B.B. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261. Br. J. Pharmacol. 121:1997;353-360.
37. Bevan N., Palmer T., Drmota T., Wise A., Coote J., Milligan G., Rees S. Functional analysis of a human A(1) adenosine receptor/green fluorescent protein/G(i1)alpha fusion protein following stable expression in CHO cells. FEBS Lett. 462:1999;61-65.
38. Kull B., Arslan G., Nilsson C., Owman C., Lorenzen A., Schwabe U., Fredholm B.B. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors. Biochem. Pharmacol. 57:1999;65-75.
39. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
40. Hill R.J., Oleynek J.J., Hoth C.F., Kiron M.A., Weng W., Wester R.T., Tracey W.R., Knight D.R., Buchholz R.A., Kennedy S.P. Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptors. J. Pharmacol. Exp. Ther. 280:1997;122-128.
41. Greer F., Nagy L., Graham T.E., Bonen A. The presence of adenosine receptors in skeletal muscle. The Physiologist. 43:2001;. (Abstract).
42. Linden J., Thai T., Figler H., Jin X., Robeva A.S. Characterization of human A(2B) adenosine receptors: radioligand binding, Western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Mol. Pharmacol. 56:1999;705-713.
43. Ji X.D., Jacobson K.A. Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors. Drug Des. Discov. 16:1999;217-226.
44. Klotz K.N., Hessling J., Hegler J., Owman C., Kull B., Fredholm B.B., Lohse M.J. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch. Pharmacol. 357:1998;1-9.
45. Gao Z., Chen T., Weber M.J., Linden J. A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. cross-talk between cyclic AMP and protein kinase c pathways. J. Biol. Chem. 274:1999;5972-5980.
46. Withers D.J., Bloom S.R., Rozengurt E. Dissociation of cAMP-stimulated mitogenesis from activation of the mitogen-activated protein kinase cascade in Swiss 3T3 cells. J. Biol. Chem. 270:1995;21411-21419.
47. Marchal S., Cassar-Malek I., Magaud J.P., Rouault J.P., Wrutniak C., Cabello G. Stimulation of avian myoblast differentiation by triiodothyronine: possible involvement of the cAMP pathway. Exp. Cell Res. 220:1995;1-10.
48. Zheng Z., Wang Z.M., Delbono O. Charge movement and transcription regulation of L-type calcium channel alpha(1S) in skeletal muscle cells. J. Physiol. 540:2002;397-409.
49. Osawa H., Robey R.B., Printz R.L., Granner D.K. Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat hexokinase II gene. J. Biol. Chem. 271:1996;17296-17303.
50. Hellsten Y., Maclean D.A., Rådegran G., Saltin B., Bangsbo J. Adenosine concentrations in the interstitium of resting and contracting human skeletal muscle. Circulation. 98:1998;6-8.